在衰老的丸癌幸存者中生化性低孕腺症:临床挑战
Sophie D Fosså1,2, Lars J Bjerner3, Torgrim Tandstad4,5
1Department of Oncology, Oslo University Hospital, Oslo, Norway.
European urology open science
|February 3, 2025
概括
与普通人群相比,衰老的丸癌幸存者 (TCSs) 患生化性低子腺症的风险明显更高. 这种增加的风险与年龄和治疗强度有关,影响长期健康结果.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 男人的健康 男人的健康
背景情况:
- 与对照人群相比,老化丸癌幸存者 (TCSs) 中生物化学性低子体的纵向数据很少.
- 丸癌 (TC) 治疗可以长期影响荷尔蒙健康.
研究的目的:
- 为了确定生物化学性性阴性腺症在老化TCSs中的流行率和发展,与一般人口对照对比.
- 调查年龄和治疗强度与TCSs. 低子腺症的关联.
主要方法:
- 血清总和自由水平在593个TCS和578个对照中被测量了两个调查波.
- 生物化学性阴性过敏症是使用已确定的水平值来定义的.
- 多变量后勤回归分析了与年龄和治疗强度 (手术,放射治疗,化疗) 的关联.
主要成果:
- 随着时间的推移,阴性腺的患病率从TCS中增加了12%至41%,对照组增加了5%至11%.
- 在诊断后的30年里,阴性双胞胎症的概率与年龄和治疗强度相关.
- 与对照组相比,TCS的阴性腺体缺陷风险高出三倍,与不良健康结果相关.
结论:
- 生物化学性低子腺症在老化TCS中明显更为普遍,受年龄和治疗强度的影响.
- 在TCS中,晚期出现的阴性双胞胎症与增加的不良健康结果有关.
- 在TCSs的随访期间,定期对丸激素的监测至关重要.
相关概念视频
Menopause
129
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
129
Infertility in Males
238
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
238
Testosterone: Functions and Regulation
526
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
526
Disorders of the Male Reproductive System
309
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
309
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K


